menu search

Araris Biotech supported with CHF 2.5M Swiss accelerator grant from Innosuisse to develop antibody-drug conjugate candidates

The Swiss Accelerator programme’s total funding grant amounted to CHF 112M (~$125 million) with support per project amounting to a maximum of CHF 2.5M (~$2.8 million). We are honoured to have been … Read Full Story at source (may require registration) The post Araris Biotech supported with CHF 2.5M Swiss accelerator grant from Innosuisse to develop antibody-drug conjugate candidates appeared first on ForexTV... Read More
Posted: May 8 2023, 04:44
Author Name: forextv
Views: 103011

Search within

Pages Search Results: